The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism

Total Page:16

File Type:pdf, Size:1020Kb

The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism Supplementary Online Content Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. Published online August 10, 2016. doi:10.1001/jamasurg.2016.2310. eAppendix. The American Association of Endocrine Surgeons (AAES) Guidelines for Definitive Management of Primary Hyperparathyroidism eTable 1. Table of Contents: The American Association of Endocrine Surgeons (AAES) Guidelines for Definitive Management of Primary Hyperparathyroidism eTable 2. Common Secondary Causes of Elevated PTH Levels eTable 3. Selected Results of the Two Most Commonly Utilized IPM Protocols eTable 4. Parathyroid Carcinoma in Large Retrospective Series This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/28/2021 eAppendix. The American Association of Endocrine Surgeons (AAES) Guidelines for Definitive Management of Primary Hyperparathyroidism ABSTRACT Importance Primary hyperparathyroidism (pHPT) is a common clinical problem for which the only definitive management is surgery. Surgical management has evolved considerably during the last several decades. Objective To develop evidence-based guidelines to enhance the appropriate, safe, and effective practice of parathyroidectomy. Evidence Review A multidisciplinary panel used PubMed to reviewed the medical literature from January 1, 1985, to July 1, 2015. Levels of evidence were determined using the American College of Physicians grading system, and recommendations were discussed until consensus. Findings Initial evaluation should include 25-hydroxyvitamin D measurement, 24-hour urine calcium measurement, dual-energy x-ray absorptiometry, and supplementation for vitamin D deficiency. Parathyroidectomy is indicated for all symptomatic patients, should be considered for most asymptomatic patients, and is more cost-effective than observation or pharmacologic therapy. Cervical ultrasonography or other high-resolution imaging is recommended for operative planning. Patients with nonlocalizing imaging remain surgical candidates. Preoperative parathyroid biopsy should be avoided. Surgeons who perform a high volume of operations have better outcomes. The possibility of multigland disease should be routinely considered. Both focused, image-guided surgery (minimally invasive parathyroidectomy) and bilateral exploration are appropriate operations that achieve high cure rates. For minimally invasive parathyroidectomy, intraoperative parathyroid hormone monitoring via a reliable protocol is recommended. Minimally invasive parathyroidectomy is not routinely recommended for known or suspected multigland disease. Ex vivo aspiration of resected parathyroid tissue may be used to confirm parathyroid tissue intraoperatively. Clinically relevant thyroid disease © 2016 American Medical Association. All rights reserved. 2 Downloaded From: https://jamanetwork.com/ on 09/28/2021 should be assessed preoperatively and managed during parathyroidectomy. Devascularized normal parathyroid tissue should be autotransplanted. Patients should be observed postoperatively for hematoma, evaluated for hypocalcemia and symptoms of hypocalcemia, and followed up to assess for cure defined as eucalcemia at more than 6 months. Calcium supplementation may be indicated postoperatively. Familial pHPT, reoperative parathyroidectomy, and parathyroid carcinoma are challenging entities that require special consideration and expertise. Conclusions and Relevance Evidence-based recommendations were created to assist clinicians in the optimal treatment of patients with pHPT. INTRODUCTION The surgical treatment of primary hyperparathyroidism (pHPT) has undergone extensive change in the last two decades. Laboratory testing, point of care access, radiographic imaging, operative techniques, intraoperative adjuncts, and other areas of surgical care have all rapidly evolved. With these transformations has come significant potential for subjective interpretation and variable management. Recognizing these innovations and challenges, the American Association of Endocrine Surgeons (AAES) determined the need to develop evidence-based clinical guidelines to enhance the safe and effective practice of surgery to achieve definitive treatment of pHPT. Intended for surgeons who perform parathyroidectomy, as well as their team members, these guidelines supply a broad medical update on the clinical spectrum of pHPT and in addition specifically aim to: 1) Provide surgical caregivers with a current background understanding of the epidemiology and pathogenesis of pHPT. 2) Outline the process for diagnosis of pHPT by laboratory studies and clinical manifestations (both subjective and objective) and once a diagnosis is established, examine the indications for surgical intervention. © 2016 American Medical Association. All rights reserved. 3 Downloaded From: https://jamanetwork.com/ on 09/28/2021 3) Detail the pre- and intra-operative management of pHPT including creation of a patient-specific operative plan based on available resources, surgeon experience, and patient characteristics. 4) Delineate methods for safe and effective postoperative management including a definition of cure and an algorithm for managing operative failure. pHPT is a common clinical problem for which the only definitive management is surgical intervention. The presentation, diagnosis and medical management have recently been addressed in several influential statements including the National Institutes of Health (NIH) consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism1, the American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons guidelines for the diagnosis and management of primary hyperparathyroidism2, and several international workshops3-5, which offer selected surgical suggestions as a portion of their content. The guidelines presented here specifically focus on the surgical management of pHPT with the goal of achieving cure as safely and efficiently as possible. METHODS Writing Group, Topics, and Analysis of Literature Evidence With the approval of the AAES Council at the project’s inception, a multidisciplinary panel of endocrinologists, pathologists, surgeons and radiologists was appointed by the AAES President to include broad-based complementary expertise. Eleven of the 16 writing group members have been AAES presidents, officers or council members. In January 2014, individual writing subcommittees were established for each of 17 topics and were comprised of 2-5 coauthors. Topic outlines were vigorously discussed to consensus. Search parameters for the worldwide medical literature were set from January 1985 to July 1, 2015 (30 years of the most recent data and research available in the field). At the discretion of the authors, this time frame was expanded to allow for inclusion of “classic literature” i.e. large and/or landmark articles to give historical reference or to illustrate time-tested principles of management. For each topic, the primary co-author then conducted a PubMed Medical Subject Heading (MESH) search using Boolean logic for MESH terms. Limitations were applied to select publications containing an abstract (English Language) and published in © 2016 American Medical Association. All rights reserved. 4 Downloaded From: https://jamanetwork.com/ on 09/28/2021 abridged index medicus (AIM), otherwise known as core clinical journals in PubMed. Results yielded a broad category of publication types which were then critically appraised to generate a pertinent bibliography. Particular value was assigned to study design (e.g. randomized controlled trials (RCT), meta-analyses and large single-center reports). Text and Recommendations To craft the specific content, all topics went through a rigorous process of determining the quality of the evidence, drafting text and recommendations supported by evidence, and amending that material in discussion to consensus. The draft document was discussed in detail during regular teleconferences as well as by email and in person. Expert opinion was vigorously examined. Editing to eliminate redundancy, verify referenced data, and ensure that the material met the guiding principles was performed by 5 committee members (SMW, TSW, DTR, JAL, and SEC). Grading of Practice Recommendations The writing group adopted the American College of Physicians (ACP) grading system for evidence- based clinical guidelines, which employs a validated scale to critically interpret and evaluate the strength and quality of the evidence 6. The ACP writing guidelines were drafted in 1981 and have undergone periodic revisions; the most recent version from 2010 was utilized. In brief, the ACP system applies the designations “Strong” when benefits clearly outweigh risks and/or the recommendation should be applied to all or most patients without reservation, “Weak” when benefits are finely balanced with risks or appreciable uncertainty exists, and “Insufficient” when the evidence to support a recommendation is conflicting, lacking, or of poor quality; in these circumstances the writing group provided recommendations based on expert interpretation of the available data. Quality assessment is followed by a formal interpretation about the evidence strength to provide guidance on how to best apply the recommendation to individual
Recommended publications
  • When Is It Minimally Invasive?
    ORIGINAL ARTICLE Incision Length for Standard Thyroidectomy and Parathyroidectomy When Is It Minimally Invasive? Laurent Brunaud, MD; Rasa Zarnegar, MD; Nobuyuki Wada, MD; Philip Ituarte, PhD; Orlo H. Clark, MD; Quan-Yang Duh, MD Hypothesis: Current techniques for open conven- parathyroidectomy (PϽ.001). It was 4.1 cm for bilateral tional thyroidectomy or parathyroidectomy have evolved parathyroid exploration, but was reduced to 3.2 and 2.8 to enable a shorter incision (main proposition), and the cm for unilateral (PϽ.001) and focal (PϽ.001) explora- length of the incision is influenced by objective factors. tions, respectively. By multiple regression analysis, thy- roid specimen volume and patient body mass index were Design: Case series. independent predictors of incision length in thyroidec- tomy. Extent of exploration and resident training level Setting: University referral center. were independent predictors of incision length in parathyroidectomy. Patients and Intervention: Retrospective study of the most recent 200 primary consecutive routine thyroid and Conclusions: Current techniques for open conven- parathyroid operations (excluding neck dissections). tional thyroidectomy or parathyroidectomy have evolved to enable a shorter incision. Thyroid volume, patient body Main Outcome Measures: The length of incision was mass index, extent of the planned parathyroid explora- routinely measured with a ruler before the incision. tion, and the resident clinical training stage are impor- Univariate and multivariate analysis was performed to dis- tant variables for incision length in open operation and tinguish variables affecting length of incision. should be taken into account when minimally invasive thyroidectomy and parathyroidectomy are evaluated. Results: Mean length of the incision was 5.5 cm for to- tal thyroidectomy, 4.6 cm for lobectomy, and 3.5 cm for Arch Surg.
    [Show full text]
  • Inadvertent Parathyroidectomy During Thyroid Surgery for Papillary Thyroid Carcinoma and Postoperative Hypocalcemia
    ORIGINAL J Korean Thyroid Assoc ARTICLE Vol. 5, No. 1, May 2012 Inadvertent Parathyroidectomy during Thyroid Surgery for Papillary Thyroid Carcinoma and Postoperative Hypocalcemia Dongbin Ahn, MD1, Jin Ho Sohn, MD, PhD1, Jae Hyug Kim, MD1, Ji Young Park, MD2 and Junesik Park, MD, PhD3 Departments of Otolaryngology-Head and Neck Surgery1, Pathology2, School of Medicine, Kyungpook National University, Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Catholic University of Daegu3, Daegu, Korea Background and Objectives: The aim of this article is to report our experience of inadvertent parathyroidectomy during thyroid surgery and to analyze its associated factors and clinical implications. In addition, we attempted to determined causative factors that result in permanent hypocalcemia after thyroid surgery. Materials and Methods: We performed a retrospective review of 500 patients who underwent thyroid surgery for the treatment of papillary thyroid carcinoma from 2004 to 2008. Results: Inadvertent parathyroidectomy was identified in 7.4% of patients and only 1 parathyroid gland was inadvertently removed in most cases. The incidence of inadvertent parathyroidectomy was not associated with gender, age, type of surgical procedure, tumor size, coexisting Hashimoto’s thyroiditis (HT), extra-thyroidal extension (ETE), lymph node (LN) metastasis, and surgeon’s experience. Nor was inadvertent parathyroidectomy associated with permanent postoperative hypocalcemia. Although operating time >120 min, ETE, and total thyroidectomy (TT) with central neck dissection (CND) were found to be related to permanent hypocalcemia on univariate analysis, tumor size ≥1 cm and surgeon’s experience ≤5 years was statistically associated with permanent hypocalcemia on both univariate and multivariate analyses. Conclusion: Although inadvertent parathyroidectomy is not an uncommon complication of thyroid surgery, it appears to have only modest clinical implications.
    [Show full text]
  • Postoperative Calcium Requirements in 6000 Patients Undergoing
    Postoperative Calcium Requirements in 6,000 Patients Undergoing Outpatient Parathyroidectomy: Easily Avoiding Symptomatic Hypocalcemia Marie Vasher, MD, Arnold Goodman, MD, FACS, Douglas Politz, MD, FACS, FACE, James Norman, MD, FACS, FACE BACKGROUND: To determine the amount and duration of supplemental oral calcium for patients with varying clinical presentations discharged immediately after surgery for primary hyperparathyroidism. STUDY DESIGN: A 4-year, prospective, single-institution study of 6,000 patients undergoing parathyroidectomy for primary hyperparathyroidism and discharged within 2.5 hours. Based on our previous studies, patients are started on a sliding scale of oral calcium determined by a number of preoperative measures (ie, serum calcium, body weight, osteoporosis) beginning 3 hours post- operation and decreasing to a maintenance dose by week 3. Patients reported all hypocalcemia symptoms daily for 2 weeks. RESULTS: Seven parameters were found to have a substantial impact on the amount of calcium required to prevent symptomatic hypocalcemia: preoperative serum calcium Ͼ12 mg/dL, Ͼ13 mg/dL, and Ͼ13.5 mg/dL, bone density T score less than Ϫ3, morbid obesity, removal of Ͼ1 parathyroid, and manipulation/biopsy of all remaining glands (all p Ͻ 0.05). Each independent variable increased the daily calcium required by 315 mg/day. Using our scaled protocol, Ͻ8% of patients showed symptoms of hypocalcemia, nearly all of whom were successfully self-treated with additional oral calcium. Only 6 patients (0.1%) required a visit to the emergency room for IV calcium, all occurring on postoperative day 3 or later. CONCLUSION: After outpatient parathyroidectomy, a specific calcium protocol has been verified that elimi- nates development of symptomatic hypocalcemia in Ͼ92% of patients, identifies patients at high risk for hypocalcemia, and allows self-medication with confidence in a predictable fashion for those patients in whom symptoms develop.
    [Show full text]
  • Radioguided Surgery of Primary Hyperparathyroidism Using the Low
    Radioguided Surgery of Primary Hyperparathyroidism Using the Low-Dose 99mTc- Sestamibi Protocol: Multiinstitutional Experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS) Domenico Rubello, MD1; Maria Rosa Pelizzo, MD2; Giuseppe Boni, MD3; Riccardo Schiavo, MD4; Luca Vaggelli, MD5; Giuseppe Villa, MD6; Sergio Sandrucci, MD7; Andrea Piotto, MD2; Gianpiero Manca, MD3; Pierluigi Marini, MD8; and Giuliano Mariani, MD3 1Nuclear Medicine Service, “S. Maria della Misericordia” Hospital, Rovigo, Italy; 2Department of Surgery, University of Padua Medical School, Padua, Italy; 3Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy; 4Nuclear Medicine Service, “S. Camillo-Forlanini” Hospital, Rome, Italy; 5Nuclear Medicine Service, “Careggi” University Hospital, Florence, Italy; 6Nuclear Medicine Service, “S. Martino” University Hospital, Genoa, Italy; 7Department of Surgery, University of Turin Medical School, Turin, Italy; and 8Division of Surgery, “S. Camillo-Forlanini” Hospital, Rome, Italy (11%) of transient postoperative hypocalcemia. The probe was 99m This study evaluated the accuracy of 99mTc-sestamibi scintigra- of little help in patients with concomitant Tc-sestamibi–avid phy and neck ultrasonography in patients with primary hyper- thyroid nodules and not helpful at all in patients with negative parathyroidism (PHPT) and the role of intraoperative hand-held scan findings preoperatively. IQPTH measurement helped to ␥-probes in minimally invasive radioguided surgery (MIRS) of disclose some cases of multigland parathyroid disease. Con- patients with a high likelihood of a solitary parathyroid adenoma clusion: 99mTc-Sestamibi scintigraphy, especially if combined (PA). The study was undertaken under the aegis of the Italian with neck ultrasonography, is highly accurate in selecting PHPT Study Group on Radioguided Surgery and Immunoscintigraphy candidates for MIRS.
    [Show full text]
  • Continuous Rhpth (1–34) Treatment in Chronic Hypoparathyroidism
    ID: 20-0009 -20-0009 C T Fuss and others Continuous rhPTH (1-34) in ID: 20-0009; May 2020 hypoparathyroidism DOI: 10.1530/EDM-20-0009 Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism Carmina Teresa Fuss1, Stephanie Burger-Stritt1, Silke Horn1, Ann-Cathrin Koschker1, Kathrin Frey1, Almuth Meyer2 and Stefanie Hahner1 Correspondence should be addressed 1Division of Endocrinology and Diabetology, Department of Medicine I, University Hospital Würzburg, Würzburg, to S Hahner Germany and 2Division of Endocrinology and Diabetology, Department of Internal Medicine, Helios Klinikum Erfurt, Email Erfurt, Germany [email protected] Summary Standard treatment of hypoparathyroidism consists of supplementation of calcium and vitamin D analogues, which does not fully restore calcium homeostasis. In some patients, hypoparathyroidism is refractory to standard treatment with persistent low serum calcium levels and associated clinical complications. Here, we report on three patients (58-year-oldmale,52-year-oldfemale,and48-year-oldfemale)sufferingfromseveretreatment-refractorypostsurgical hypoparathyroidism. Two patients had persistent hypocalcemia despite oral treatment with up to 4 µg calcitriol and up to 4 g calcium per day necessitating additional i.v. administration of calcium gluconate 2–3 times per week, whereas the third patient presented with high frequencies of hypocalcemic and treatment-associated hypercalcemic episodes. S.c. administration of rhPTH (1–34) twice daily (40 µg/day) or rhPTH (1–84) (100 µg/day) only temporarily increased serum calcium levels but did not lead to long-term stabilization. In all three cases, treatment with rhPTH (1–34) as continuous s.c. infusion via insulin pump was initiated. Normalization of serum calcium and serum phosphate levels was observed within 1 week at daily 1–34 parathyroid hormone doses of 15 µg to 29.4 µg.
    [Show full text]
  • Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism
    Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism Amanda M. Laird, MD*, Steven K. Libutti, MD KEYWORDS Primary hyperparathyroidism Parathyroidectomy Intraoperative parathyroid hormone Surgery Minimally invasive parathyroidectomy KEY POINTS The gold-standard surgical management of primary hyperparathyroidism (10HPT) is cer- vical exploration and identification of all 4 parathyroid glands. Imaging techniques, including ultrasound, sestamibi scans, and 4D-CT scans, have made identification of single parathyroid adenomas possible. Intraoperative parathyroid hormone (PTH) monitoring is a method to confirm biochemical cure before a patient leaves the operating room. There is some debate surrounding optimal surgical management of 10HPT because cure rates between minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) are equivalent. Advantages of MIP include reduced operative time, reduced recovery time, less postop- erative pain, and lower complication rate with respect to injury to parathyroid glands and recurrent laryngeal nerves. INTRODUCTION 10HPT is a common disease, with a prevalence as high as 3%.1 Many advances in the surgical management of 10HPT have been made since the first parathyroidectomy was performed by Felix Mandl in 1925.2 Traditional surgical management consists of identification of all 4 parathyroid glands through a transverse cervical incision.3 Bet- ter understanding of the disease, interest in the practice of endocrine neck surgery, The authors have nothing to disclose. Montefiore Medical Center/Albert Einstein College of Medicine, Greene Medical Arts Pavilion, 3400 Bainbridge Avenue, 4th Floor, Bronx, NY 10467, USA * Corresponding author. E-mail address: [email protected] Surg Oncol Clin N Am 25 (2016) 103–118 http://dx.doi.org/10.1016/j.soc.2015.08.012 surgonc.theclinics.com 1055-3207/16/$ – see front matter Ó 2016 Elsevier Inc.
    [Show full text]
  • Endocrine Surgery Goals and Objectives
    Lenox Hill Hospital Department of Surgery Endocrine Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology of the diseases listed below for this rotation, with the pertinent clinical and laboratory findings, differential diagnosis and therapeutic options including preventive measures, and procedural knowledge. They must show that they are able to gather accurate and relevant information using medical interviewing, physical examination, appropriate diagnostic workup, and use of information technology. They must be able to synthesize and apply information in the clinical setting to make informed recommendations about preventive, diagnostic and therapeutic options, based on clinical judgement, scientific evidence, and patient preferences. They should be able to prescribe, perform, and interpret surgical procedures listed below for this rotation. All Residents are expected to understand: 1. Normal physiology and anatomy of the thyroid glands. 2. Normal physiology and anatomy of the parathyroid glands. 3. Normal physiology and anatomy of the adrenal glands 4. Normal physiology of the pancreatic neuroendocrine cells. 5. Normal physiology of the pituitary gland. Disease-Based Learning Objectives: Hyperfunctioning Thyroid and Hypothyroid State: 1. Physiology of Grave’s disease and toxic goiter. 2. Management of a patient in hyperthyroid storm. 3. Medical and surgical treatment options for hyperthyroidism. 4. Physiology of Hashimoto’s thyroiditis and hypothyroidism. Thyroid Neoplasm: 1. Workup of a cold thyroid nodule. 2. Surgical management of papillary, follicular, medullary, and anaplastic thyroid carcinoma. 3. Adjuvant therapy for thyroid neoplasms. 4. Postoperative medical management and long-term follow-up of thyroid cancer. Hyperparathyroidism: 1. Diagnosis and work-up of hypercalcemia and primary, secondary, and tertiary hyperparathyroidism.
    [Show full text]
  • Pseudoischemic Electrocardiogram in Myasthenia Gravis with Thymoma Published Online in Wiley Interscience
    Address for correspondence: Nicola Mumoli, MD CaseShort Communication Livorno Hospital Department of Internal Medicine Viale Alfieri 36 Pseudoischemic Electrocardiogram in 57100 Livorno, Italy Myasthenia Gravis with Thymoma: [email protected] Reversibility After Thymectomy Patrizio Chiavistelli, MD, Marco Cei, MD, Giovanni Carmignani, MD, Carlo Bartolomei, MD Nicola Mumoli, MD Department of Internal Medicine, Livorno Hospital, Livorno, Italy Abnormal ST T-wave changes can be found at presentation in various noncoronary disorders; misinterpretation of these patterns as ischemic heart disease can lead to erroneous diagnosis and treatment. Here we present a case of myasthenia gravis (MG) with thymoma, in which the resting electrocardiogram (ECG) led to a misleading diagnosis of myocardial ischemia. After thymectomy, the ECG resumed a normal pattern. Myasthenia gravis is not usually considered in the differential diagnosis of conditions associated with an abnormal ECG. The combination of dysphagia, dyspnoea, ECG changes, and creatine kinase (CK) elevations may easily bring to mind an erroneous and possibly deleterious diagnosis of myocardial ischemia. Introduction did not seek medical attention. At the beginning of the The resting 12-lead electrocardiogram (ECG) remains at current year, he reported a flu-like illness, with spontaneous the center of the diagnostic pathways of acute coronary recovery, but shortly afterward he experienced dyspnea, syndromes (ACSs), either with1 or without ST segment dysphagia, and weight loss (37 kg). One month before elevation,2 because it serves as an invaluable tool for admission, he underwent fiberoptic endoscopy of the nose, both diagnosis and risk stratification. Nevertheless, as is pharynx, and larynx because of dysphonia, without any universally accepted, the predictive value of any diagnostic evidence of an active disease.
    [Show full text]
  • Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist
    [CANCER RESEARCH 26 Part I, 551-574, April 1966] Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist LLOYDW. LAW National Cancer Institute, Bethesda, Maryland This presentation will be concerned with 2 general topics: organ to other sites occurs with a selective seeding in spleen (a) our present knowledge of thymic structure and function, lymph nodes, and other lymphoid organs. but particularly the latter, as revealed by the results of recent For a more detailed discussion of the ontogeny of the thymus experiments in several species of animals following early thymic and its microscopic anatomy, the reader is referred to the studies ablation, and (b) consideration of the precise role of the thymus in of Smith (97) and of Ruth et al. (92). the initiation and suppression of neoplastic growths. Pertaining to Thymic Structure and Function Origin and Early Structure of the Thymus In most species the thymus is located in the upper anterior The thymus is a compound organ consisting of 3 quite different part of the chest. Exceptions are the chicken and guinea pig. cell systems: (a) lymphoid cells, (b) reticulum cells, and (c) The absolute size varies from species to species but the absolute e[)ithehal cells. The latter 2 may be referred to as the epithelial size of thymic lobules appears to be remarkably uniform in the reticulum cell complex. The thymus in mammals arises as various species, suggesting that there may be a critical limit for paired structures from the endoderm of the 3rd and 4th branchial the size of a thymic lobule.
    [Show full text]
  • Analysis of the Role of Thyroidectomy and Thymectomy in the Surgical Treatment of Secondary Hyperparathyroidism
    Am J Otolaryngol 40 (2019) 67–69 Contents lists available at ScienceDirect Am J Otolaryngol journal homepage: www.elsevier.com/locate/amjoto Analysis of the role of thyroidectomy and thymectomy in the surgical ☆ treatment of secondary hyperparathyroidism T Mateus R. Soares, Graziela V. Cavalcanti, Ricardo Iwakura, Leandro J. Lucca, Elen A. Romão, ⁎ Luiz C. Conti de Freitas Division of Head and Neck Surgery, Department of Ophthalmology, Otolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School, University of Sao Paulo, Brazil ARTICLE INFO ABSTRACT Keywords: Purpose: Parathyroidectomy can be subtotal or total with an autograft for the treatment of renal hyperpar- Parathyroidectomy athyroidism. In both cases, it may be extended with bilateral thymectomy and total or partial thyroidectomy. Hyperparathyroidism Thymectomy may be recommended in combination with parathyroidectomy in order to prevent mediastinal Thymectomy recurrence. Also, the occurrence of thyroid disease observed in patients with hyperparathyroidism is poorly Thyroidectomy understood and the incidence of cancer is controversial. The aim of the present study was to report the ex- perience of a single center in the surgical treatment of renal hyperparathyroidism and to analyse the role of thyroid and thymus surgery in association with parathyroidectomy. Materials and methods: We analysed parathyroid surgery data, considering patient demographics, such as age and gender, and surgical procedure data, such as type of hyperparathyroidism, associated thyroid or thymus surgery, surgical duration and mediastinal recurrence. Histopathological results of thyroid and thymus samples were also analysed. Results: Medical records of 109 patients who underwent parathyroidectomy for secondary hyperparathyroidism were reviewed. On average, thymectomy did not have impact on time of parathyroidectomy (p = 0.62) even when thyroidectomy was included (p = 0.91).
    [Show full text]
  • Hypoparathyroidism, Sensorineural
    Joseph et al. BMC Endocrine Disorders (2019) 19:111 https://doi.org/10.1186/s12902-019-0438-4 CASE REPORT Open Access Hypoparathyroidism, Sensorineural deafness and renal disease (Barakat syndrome) caused by a reduced gene dosage in GATA3: a case report and review of literature Anne D. D. Joseph1* , Nirmala D. Sirisena2, Thirunavukarasu Kumanan1, Vathualan Sujanitha1, Veronika Strelow3, Raina Yamamoto3, Stefan Wieczorek3 and Vajira H. W. Dissanayake2 Abstract Background: Barakat syndrome is an autosomal dominant rare genetic disease caused by haploinsufficiency of the GATA binding protein 3 (GATA3) gene. It is also known as HDR syndrome, and is characterized by varying degrees of hypoparathyroidism, sensorineural deafness and renal disease. This is the first report of a heterozygous GATA3 whole gene deletion causing HDR syndrome in a Sri Lankan family. Case presentation: A 13-year-old boy with an acute febrile illness, hypocalcaemia and bilateral carpopedal spasm was referred for evaluation. A past medical history of treatment for persistent hypocalcaemic symptoms since the age of 7 months was obtained. Biochemical investigations showed persistent low serum corrected calcium levels with hyperphosphataemia, hypomagnesaemia, low parathyroid hormone levels, hypercalciuria, and low total 25-hydroxy vitamin D levels. His renal functions and renal sonography were normal. Audiometry showed bilateral moderate to severe sensorineural hearing loss. On screening, his mother was also found to have asymptomatic hypocalcaemia, hypomagnesaemia, hyperphosphataemia, hypercalciuria and low total 25-hydroxy vitamin D levels. She had impaired renal functions and chronic parenchymal changes in the renal scan. Audiometry showed bilateral profound sensorineural hearing loss. Genetic analysis using multiplex-ligation dependent probe amplification showed a reduced gene dosage for GATA3 that is consistent with a heterozygous whole gene deletion in both the child and mother.
    [Show full text]
  • Surgical Indications and Techniques for Adrenalectomy Review
    THE MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL DOI: 10.14744/SEMB.2019.05578 Med Bull Sisli Etfal Hosp 2020;54(1):8–22 Review Surgical Indications and Techniques for Adrenalectomy Mehmet Uludağ,1 Nurcihan Aygün,1 Adnan İşgör2 1Department of General Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey 2Department of General Surgery, Bahcesehir University Faculty of Medicine, Istanbul, Turkey Abstract Indications for adrenalectomy are malignancy suspicion or malignant tumors, non-functional tumors with the risk of malignancy and functional adrenal tumors. Regardless of the size of functional tumors, they have surgical indications. The hormone-secreting adrenal tumors in which adrenalectomy is indicated are as follows: Cushing’s syndrome, arises from hypersecretion of glucocorticoids produced in fasciculata adrenal cortex, Conn’s syndrome, arises from an hypersecretion of aldosterone produced by glomerulosa adrenal cortex, and Pheochromocytomas that arise from adrenal medulla and produce catecholamines. Sometimes, bilateral adre- nalectomy may be required in Cushing's disease due to pituitary or ectopic ACTH secretion. Adenomas arise from the reticularis layer of the adrenal cortex, which rarely releases too much adrenal androgen and estrogen, may also develop and have an indication for adrenalectomy. Adrenal surgery can be performed by laparoscopic or open technique. Today, laparoscopic adrenalectomy is the gold standard treatment in selected patients. Laparoscopic adrenalectomy can be performed transperitoneally or retroperitoneoscopi- cally. Both approaches have their advantages and disadvantages. In the selection of the surgery type, the experience and habits of the surgeon are also important, along with the patient’s characteristics. The most common type of surgery performed in the world is laparoscopic transabdominal lateral adrenalectomy, which most surgeons are more familiar with.
    [Show full text]